Edison Investment Research - Bionaturis (ADL) ADL Bionatur Solutions - CMO business driving growth

Report

Edison Investment Research

Sean Conroy

ADL Bionatur Solutions - CMO business driving growth

ADL Bionatur Solutionsâ€™ (ADL-BS) 9M19 results show â‚¬2.16m adjusted EBITDA and 127% year-on-year operating revenue growth to â‚¬33.2m, driven by 195% growth in contract manufacturing (CMO). On 2 December it announced a new seven-year CMO contract with a Swiss biotech client worth â‚¬20m to produce two novel cosmetics and/or nutrition products. ADL-BS is on track to report positive full-year EBITDA and maintained its FY19 revenue guidance of â‚¬50m. We now obtain an EV of â‚¬165.8m, translating into an equity valuation of â‚¬2.94 per share (from â‚¬3.02 previously) after adjusting for net debt.

11/12/2019 8 EN

Underlying

Bionaturis

ADL Bionatur Solutions SA Formerly known as Bioorganic Research and Services SA. ADL BIONATUR SOLUTIONS SA (Bionatur), formerly known as Bioorganic Research and Services SA, is a Spain-based company engaged in the management and advice in the development of organic chemical processes carried out by third party entities. Among the chemical projects, the Company comprises the examination and interpretation of samples from waste treatment works, valuation of biological activities and retrosynthetic analysis. The Company's subsidiaries are BBD BioPhenix SL, a San Sebastian-based biotechnology company and Zera Intein Protein Solutions SL.

See profile

ES0184980003 Madrid Stock Exchange Spain

Provider

Edison Investment Research

Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisors and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

See profile

Analysts

Sean Conroy

Other Reports on these Companies

Edison Investment Research

ADL Bionatur Solutions - â‚¬25m debt financing to fund current strategy

ADL Bionatur Solutions (ADL-BS) announced on 12 August 2019 that it has agreed to obtain â‚¬25m in debt financing with Kartesia, a private lender, at a rate of Euriobor plus 5% per year with a one-time 7% fee on repayment. Gross proceeds will be used to fully fund the companyâ€™s existing capex plans to modernise ADL-BSâ€™s contract manufacturing (CMO) facilities (totalling 2,400m3 in fermentation capacity), to provide the working capital needed to respond to its CMO client demands, and to refinance â‚¬5.7m of existing debt. Altogether, ADL-BS expects this debt financing to fully fund the comp...

August 14, 2019 August 14, 2019 2 EN

Edison Investment Research

ADL Bionatur Solutions - New contract to serve Asia-Pacific API market

ADL Bionatur Solutions (ADL-BS) announced on 7 August 2019 that it entered into a strategic alliance with an undisclosed new customer in Japan to produce sterile active pharmaceutical ingredients (APIs). The customer is a producer of pharmaceuticals, agricultural chemicals and veterinary drugs, and the revenues associated with the contract represent â‚¬13m over the next five years.

August 8, 2019 August 8, 2019 2 EN

International Public Partnerships - Consistently and responsibly delivering

International Public Partnerships’ (INPP’s) FY23 results show that it continues to deliver consistent and predictable returns for investors, while delivering environmental and social benefits for the individuals and communities that are served by its assets. Despite this strong performance and a substantial need for private infrastructure funding, the macroeconomic environment has weighed on INPP’s share price, in common with the wider sector. Regardless, attractive returns are available from the existing portfolio with opportunities for further enhancement.

6h / 16m 6h / 16m 1 EN

Kate Heseltine

Kate Heseltine

Portobello SpA - Focus back on the operations

Portobello’s FY23 results demonstrate the primary effects of the out-of-court settlement with respect to VAT and direct taxes (a higher year-end net debt position) and the secondary effects, such as disruption to its trading activities due to management’s focus on cash generation and the company’s inability to trade as previously expected. Following the period end, two capital raises totalling €12.6m, including €3.8m by three of the executive management team, from a maximum mandated amount of €20m, have improved the company’s financial position. The requirement to improve the balance sheet fur...

7h 7h 1 EN

Kate Heseltine

Kate Heseltine

Intralot - Focus on business development in FY24

Intralot enjoyed good underlying trends in performance in FY23 with encouraging trends in its main countries of focus and further progress on profitability. The much-improved balance sheet and extension of debt maturities mean management can focus on the significant business development opportunities available in FY24 and beyond. The share price looks attractive in the absence of potential new contract wins, which could be materially enhancing to the valuation.

12h / 14m 12h / 14m 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

ADL Bionatur Solutions - CMO business driving growth

ADL Bionatur Solutions - â‚¬25m debt financing to fund current strategy

ADL Bionatur Solutions - New contract to serve Asia-Pacific API market

International Public Partnerships - Consistently and responsibly delivering

Portobello SpA - Focus back on the operations

Intralot - Focus on business development in FY24

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe